CQDM Funds Six Collaborative R&D Projects Totaling Over $10M to Accelerate Development and De‑Risk Biopharmaceutical Innovation in Québec
FIND OUT MORENEWS
ALL
Stay up to date with the latest SPM Therapeutics news and events.
Speak to one of our experts today and learn how our next generation innovations can enhance your product portfolio.